Free Trial
NASDAQ:VCNX

Vaccinex (VCNX) Stock Price, News & Analysis

Vaccinex logo
$0.89 +0.09 (+11.25%)
As of 12:35 PM Eastern

About Vaccinex Stock (NASDAQ:VCNX)

Key Stats

Today's Range
$0.89
$0.89
50-Day Range
$0.62
$1.04
52-Week Range
$0.25
$8.90
Volume
153 shs
Average Volume
56,226 shs
Market Capitalization
$2.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vaccinex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

VCNX MarketRank™: 

Vaccinex scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vaccinex.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaccinex is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaccinex is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Vaccinex's valuation and earnings.
  • Percentage of Shares Shorted

    0.20% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaccinex has recently increased by 13.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Vaccinex does not currently pay a dividend.

  • Dividend Growth

    Vaccinex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.20% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaccinex has recently increased by 13.64%, indicating that investor sentiment is decreasing significantly.
  • MarketBeat Follows

    1 people have added Vaccinex to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaccinex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    51.50% of the stock of Vaccinex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    50.11% of the stock of Vaccinex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vaccinex's insider trading history.
Receive VCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter.

VCNX Stock News Headlines

$3,200 from your phone?
No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” method, some traders could’ve turned $1,000 into $3,200 — in just 7 days. He’s now revealing this step-by-step strategy for free, and it’s designed to work straight from your phone.
See More Headlines

VCNX Stock Analysis - Frequently Asked Questions

Vaccinex's stock was trading at $0.98 on January 1st, 2025. Since then, VCNX stock has decreased by 9.2% and is now trading at $0.89.

Vaccinex, Inc. (NASDAQ:VCNX) issued its quarterly earnings results on Monday, November, 8th. The company reported ($35.70) EPS for the quarter, beating analysts' consensus estimates of ($60.90) by $25.20. The business had revenue of $0.05 million for the quarter.

Shares of Vaccinex reverse split before market open on Tuesday, February 20th 2024.The 1-14 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Vaccinex (VCNX) raised $45 million in an initial public offering (IPO) on Thursday, August 9th 2018. The company issued 3,300,000 shares at $12.00-$15.00 per share. Oppenheimer and BTIG acted as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

Shares of VCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccinex investors own include Pfizer (PFE), VBI Vaccines (VBIV), OPKO Health (OPK), Plug Power (PLUG), Vaxart (VXRT), NIO (NIO) and SNDL (SNDL).

Company Calendar

Last Earnings
11/08/2021
Today
7/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCNX
CIK
1205922
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.25 million
Pretax Margin
-4,787.89%

Debt

Sales & Book Value

Annual Sales
$388 thousand
Price / Cash Flow
N/A
Book Value
($2.59) per share
Price / Book
-0.34

Miscellaneous

Free Float
1,261,000
Market Cap
$2.31 million
Optionable
No Data
Beta
1.10
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:VCNX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners